Science 37® to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) will participate in two major virtual investor conferences this June. The first is the Lytham Partners Summer 2022 Investor Conference from June 21-22, where a presentation will be available starting June 21 at 9:00 a.m. Eastern Time. The second event is the Cowen 7th Annual FutureHealth Conference on June 23 at 3:25 p.m. Eastern Time, featuring a panel discussion on clinical trial access and affordability. Webcasts can be accessed via the company's Investor Relations page.

RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the following virtual investor conferences.

• Lytham Partners Summer 2022 Investor Conference
  Tuesday, June 21, 2022 to Wednesday, June 22, 2022
  Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern Time

• Cowen 7^th Annual FutureHealth Conference
  Panel discussion titled, “Access and Affordability in Clinical Trials,” on Thursday, June 23, 2022, at 3:25 p.m. Eastern Time

Interested parties may access the webcasts of these sessions on the “Investor Relations” section of the company’s website at: https://investors.science37.com.

About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full-stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment, 28% better retention, and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation, and data harmonization. For more information, visit https://www.science37.com.

MEDIA INQUIRIES

Drew Bustos
Science 37
Phone: (984) 377-3737
Email: pr@science37.com 

INVESTOR RELATIONS:
Caroline Paul
Gilmartin Group
Investors@science37.com

FAQ

What dates will Science 37 participate in investor conferences?

Science 37 will participate in the Lytham Partners Summer 2022 Investor Conference on June 21-22 and the Cowen 7th Annual FutureHealth Conference on June 23, 2022.

What is the format of the presentations by Science 37?

Science 37 will present virtually; a presentation for the Lytham Partners conference will be available starting June 21 at 9:00 a.m. Eastern Time, and a panel discussion at the Cowen conference will occur on June 23 at 3:25 p.m. Eastern Time.

Where can I watch the Science 37 investor conference presentations?

The webcasts of Science 37's investor conference presentations can be accessed on the 'Investor Relations' section of their website.

What is the topic of Science 37's panel discussion on June 23?

The panel discussion at the Cowen 7th Annual FutureHealth Conference will focus on 'Access and Affordability in Clinical Trials.'

What is the mission of Science 37?

Science 37 aims to enable universal access to clinical research, facilitating participation from anywhere and accelerating treatment development.